FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205909847> ?p ?o ?g. }

• W3205909847 endingPage "6795" @default.
• W3205909847 startingPage "6787" @default.
• W3205909847 abstract "This phase 4, randomized, open-label, multicenter study in healthy Indian infants and toddlers evaluated the safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) formulated in a multidose vial (MDV) or single prefilled syringe (PFS).Healthy Indian infants (6 weeks of age) were randomized 1:1 to receive either PCV13-MDV or PCV13-PFS concomitant with routine pediatric vaccines. Subjects received a single dose of either PCV13-MDV or PCV13-PFS as a 4-dose schedule (infant series: 1 dose at 6, 10, and 14 weeks of age; toddler dose: 12 months of age). Safety was assessed, including local reactions, systemic events, and adverse events (AEs). Immunogenicity 1 month after both the infant series and toddler dose was measured by concentrations of serotype-specific immunoglobulin G (IgG) antibodies and opsonophagocytic activity titers.Rates and severities of local reactions and systemic events up to 7 days after each dose of either PCV13-MDV or PCV13-PFS were generally similar, with the majority being of mild or moderate severity. PCV13-MDV had a safety profile comparable with PCV13-PFS; both groups experienced a similar frequency of AEs. PCV13-MDV elicited immune responses comparable with those induced by PCV13-PFS. Clear boosting of immune responses after the PCV13-MDV toddler dose was observed; ≥96% of subjects showed serotype-specific IgG concentrations at or above the defined thresholds 1 month after the PCV13-MDV toddler dose.PCV13-MDV was safe, well tolerated, and immunogenic in healthy Indian infants and toddlers when coadministered with routine pediatric vaccinations. Safety and immunogenicity of PCV13-MDV was comparable with PCV13-PFS.Clinicaltrials.gov: NCT03548337." @default.
• W3205909847 created "2021-10-25" @default.
• W3205909847 creator A5004965747 @default.
• W3205909847 creator A5013255727 @default.
• W3205909847 creator A5015367434 @default.
• W3205909847 creator A5026446560 @default.
• W3205909847 creator A5027264591 @default.
• W3205909847 creator A5042324494 @default.
• W3205909847 creator A5042690191 @default.
• W3205909847 creator A5042729050 @default.
• W3205909847 creator A5056066727 @default.
• W3205909847 creator A5056374148 @default.
• W3205909847 creator A5072923693 @default.
• W3205909847 creator A5075574208 @default.
• W3205909847 creator A5089678920 @default.
• W3205909847 date "2021-11-01" @default.
• W3205909847 modified "2023-10-16" @default.
• W3205909847 title "Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study" @default.
• W3205909847 cites W1827503339 @default.
• W3205909847 cites W2009118449 @default.
• W3205909847 cites W2014837879 @default.
• W3205909847 cites W2023400892 @default.
• W3205909847 cites W2043588871 @default.
• W3205909847 cites W2051213509 @default.
• W3205909847 cites W2114031476 @default.
• W3205909847 cites W2611740721 @default.
• W3205909847 cites W2737031175 @default.
• W3205909847 cites W2803396225 @default.
• W3205909847 cites W2808668519 @default.
• W3205909847 cites W2885638456 @default.
• W3205909847 cites W2944892097 @default.
• W3205909847 cites W3024176880 @default.
• W3205909847 cites W3107226521 @default.
• W3205909847 doi "https://doi.org/10.1016/j.vaccine.2021.09.029" @default.
• W3205909847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34656378" @default.
• W3205909847 hasPublicationYear "2021" @default.
• W3205909847 type Work @default.
• W3205909847 sameAs 3205909847 @default.
• W3205909847 citedByCount "0" @default.
• W3205909847 crossrefType "journal-article" @default.
• W3205909847 hasAuthorship W3205909847A5004965747 @default.
• W3205909847 hasAuthorship W3205909847A5013255727 @default.
• W3205909847 hasAuthorship W3205909847A5015367434 @default.
• W3205909847 hasAuthorship W3205909847A5026446560 @default.
• W3205909847 hasAuthorship W3205909847A5027264591 @default.
• W3205909847 hasAuthorship W3205909847A5042324494 @default.
• W3205909847 hasAuthorship W3205909847A5042690191 @default.
• W3205909847 hasAuthorship W3205909847A5042729050 @default.
• W3205909847 hasAuthorship W3205909847A5056066727 @default.
• W3205909847 hasAuthorship W3205909847A5056374148 @default.
• W3205909847 hasAuthorship W3205909847A5072923693 @default.
• W3205909847 hasAuthorship W3205909847A5075574208 @default.
• W3205909847 hasAuthorship W3205909847A5089678920 @default.
• W3205909847 hasConcept C126322002 @default.
• W3205909847 hasConcept C138496976 @default.
• W3205909847 hasConcept C147789679 @default.
• W3205909847 hasConcept C15744967 @default.
• W3205909847 hasConcept C159654299 @default.
• W3205909847 hasConcept C168563851 @default.
• W3205909847 hasConcept C185592680 @default.
• W3205909847 hasConcept C187212893 @default.
• W3205909847 hasConcept C197934379 @default.
• W3205909847 hasConcept C203014093 @default.
• W3205909847 hasConcept C22070199 @default.
• W3205909847 hasConcept C2777288759 @default.
• W3205909847 hasConcept C2778242525 @default.
• W3205909847 hasConcept C2778375690 @default.
• W3205909847 hasConcept C2778866548 @default.
• W3205909847 hasConcept C2780868878 @default.
• W3205909847 hasConcept C2781253189 @default.
• W3205909847 hasConcept C501593827 @default.
• W3205909847 hasConcept C71924100 @default.
• W3205909847 hasConcept C72092618 @default.
• W3205909847 hasConcept C86803240 @default.
• W3205909847 hasConcept C89423630 @default.
• W3205909847 hasConceptScore W3205909847C126322002 @default.
• W3205909847 hasConceptScore W3205909847C138496976 @default.
• W3205909847 hasConceptScore W3205909847C147789679 @default.
• W3205909847 hasConceptScore W3205909847C15744967 @default.
• W3205909847 hasConceptScore W3205909847C159654299 @default.
• W3205909847 hasConceptScore W3205909847C168563851 @default.
• W3205909847 hasConceptScore W3205909847C185592680 @default.
• W3205909847 hasConceptScore W3205909847C187212893 @default.
• W3205909847 hasConceptScore W3205909847C197934379 @default.
• W3205909847 hasConceptScore W3205909847C203014093 @default.
• W3205909847 hasConceptScore W3205909847C22070199 @default.
• W3205909847 hasConceptScore W3205909847C2777288759 @default.
• W3205909847 hasConceptScore W3205909847C2778242525 @default.
• W3205909847 hasConceptScore W3205909847C2778375690 @default.
• W3205909847 hasConceptScore W3205909847C2778866548 @default.
• W3205909847 hasConceptScore W3205909847C2780868878 @default.
• W3205909847 hasConceptScore W3205909847C2781253189 @default.
• W3205909847 hasConceptScore W3205909847C501593827 @default.
• W3205909847 hasConceptScore W3205909847C71924100 @default.
• W3205909847 hasConceptScore W3205909847C72092618 @default.
• W3205909847 hasConceptScore W3205909847C86803240 @default.
• W3205909847 hasConceptScore W3205909847C89423630 @default.
• W3205909847 hasIssue "46" @default.

• next